Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
The Journal of Antimicrobial Chemotherapy|January 3, 2024
Association of piperacillin/tazobactam MIC and mortality in a cohort of ceftriaxone-resistant Escherichia coli bloodstream infections treated with piperacillin/tazobactam and carbapenems: a multicentric propensity score-weighted observational cohort studyEmanuele Rando, Federica Salvati, Flavio Sangiorgi, et al.The Journal of Antimicrobial Chemotherapy|July 10, 2023
Loading dose plus continuous/extended infusion versus intermittent bolus of β-lactams for the treatment of Gram-negative bacteria bloodstream infections: a propensity score-adjusted retrospective cohort studyDavide Fiore Bavaro, Alessandra Belati, Lucia Diella, et al.Infectious Diseases and Therapy|August 31, 2023
Cefiderocol Versus Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii Complex Bloodstream Infections: A Retrospective, Propensity-Score Adjusted, Monocentric Cohort StudyDavide Fiore Bavaro, Roberta Papagni, Alessandra Belati, et al.Open Forum Infectious Diseases|October 21, 2022
Impact of a Multistep Bundles Intervention in the Management and Outcome of Gram-Negative Bloodstream Infections: A Single-Center "Proof-of-Concept" StudyDavide Fiore Bavaro, Lucia Diella, Alessandra Belati, et al.Antimicrobial Resistance and Infection Control|May 11, 2026
Clinical and cost benefit of rapid molecular screening for carbapenem-resistant organisms: a seven-year analysis in a tertiary hospitalRiccardo Bollini, Davide F Bavaro, Francesco De Fazio, et al.Tropical Medicine and Infectious Disease|November 10, 2022
Guinea Worm Disease: A Neglected Diseases on the Verge of EradicationCarmen Pellegrino, Giulia Patti, Michele Camporeale, et al.Journal of Nephrology|May 23, 2024
Safety and efficacy of tixagevimab/cilgavimab for pre-exposure prophylaxis in kidney transplant recipients: a multicenter retrospective cohort studySimona Simone, Virginia Pronzo, Francesco Pesce, et al.Open Forum Infectious Diseases|February 6, 2026
Primary Therapy for Invasive Aspergillosis With Triazoles or L-AmB: A Multicenter Retrospective StudyMatteo Rinaldi, Russell Edward Lewis, Maria Chiara Susini, et al.Antibiotics (Basel, Switzerland)|April 28, 2023
Impact of a Pro-Active Infectious Disease Consultation on the Management of a Multidrug-Resistant Organisms Outbreak in a COVID-19 Hospital: A Three-Months Quasi-Experimental StudyDavide Fiore Bavaro, Nicolò De Gennaro, Alessandra Belati, et al.BMC Infectious Diseases|April 22, 2024
Stigma and mental health among people living with HIV across the COVID-19 pandemic: a cross-sectional studyFrancesco Di Gennaro, Roberta Papagni, Francesco Vladimiro Segala, et al.Pageof 4